National Cancer Institute; Notice of Closed Meetings, 70874 [07-6034]

Download as PDF 70874 Federal Register / Vol. 72, No. 239 / Thursday, December 13, 2007 / Notices Administration, 4040 North Central Expressway, suite 900, Dallas, TX 75204, 214–253–4952, FAX: 214–253– 4970, e-mail: david.arvelo@fda.hhs.gov. SUPPLEMENTARY INFORMATION: In the Federal Register of October 11, 2007 (72 FR 57951), FDA announced that a public workshop entitled ‘‘Quality System Regulation Educational Forum on Design Controls’’ would be held on Friday, April 4, 2008. On page 57951, in the second column, the Location portion of the document is amended to read as follows: Location: The public workshop will be held at the Adam’s Mark Hotel Dallas, 400 North Olive St., Dallas, TX 75201, 214–922–8000. Directions to the facility and additional information are available at the FDA Medical Device Industry Coalition Web site at https:// www.fmdic.org/. Dated: December 7, 2007. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E7–24144 Filed 12–12–07; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings mstockstill on PROD1PC66 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, Operations and Technical Support at the NCI-Frederick. Date: January 7, 2008. Time: 8 a.m. to 4 p.m. Agenda: To review and evaluate contract proposals. Place: Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 20877. Contact Person: Lalita D. Palekar, PhD. Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer VerDate Aug<31>2005 17:10 Dec 12, 2007 Jkt 214001 Institute, 6116 Executive Blvd., Bethesda, MD 20892–7405, 301–496–7575, palekarl@mail.nih.gov. Name of Committee: National Cancer Institute Initial Review Group, Subcommittee G–Education. Date: February 12–13, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza Washington Silver Spring, 8777 Georgia Ave., Silver Spring, MD 20910. Contact Person: Sonya Roberson, PhD, Scientific Review Administrator, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd., Room 8109, Bethesda, MD 20892, 301–594–1182, robersos@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, R25(E) Special Emphasis Panel (SEP). Date: February 12, 2008. Time: 5 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza Washington Silver Spring, 8777 Georgia Ave., Silver Spring, MD 20910. Contact Person: Lynn M. Amende, PhD, Scientific Review Administrator, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard Room 8105 Bethesda, MD 20892–8328, 301–451– 4759, amendel@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research, 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: December 4, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–6034 Filed 12–12–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Advisory Council for Biomedical Imaging and Bioengineering. The meeting will be open to the public as indicated below, with attendance limited to space available. PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Biomedical Imaging and Bioengineering, NACBIB January 2008. Date: January 25, 2008. Open: 8:30 a.m. to 1 p.m. Agenda: Report from the Institute Director and other Institute staff and presentations of working group reports. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Closed: 1 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Anthony Demsey, PhD, Director, National Institute of Biomedical Imaging and Bioengineering, 6701 Democracy Blvd., Room 241, Bethesda, MD 20892. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.nibib1.nih.gov/about/NACBIB/ NACBIB.htm, where an agenda and any additional information for the meeting will be posted when available. Dated: December 5, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–6031 Filed 12–12–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute On Aging; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as E:\FR\FM\13DEN1.SGM 13DEN1

Agencies

[Federal Register Volume 72, Number 239 (Thursday, December 13, 2007)]
[Notices]
[Page 70874]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-6034]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Operations and Technical Support at the NCI-Frederick.
    Date: January 7, 2008.
    Time: 8 a.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 
20877.
    Contact Person: Lalita D. Palekar, PhD. Scientific Review 
Administrator, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd., Bethesda, MD 20892-7405, 301-496-7575, palekarl@mail.nih.gov.

    Name of Committee: National Cancer Institute Initial Review 
Group, Subcommittee G-Education.
    Date: February 12-13, 2008.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crowne Plaza Washington Silver Spring, 8777 Georgia Ave., 
Silver Spring, MD 20910.
    Contact Person: Sonya Roberson, PhD, Scientific Review 
Administrator, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Blvd., Room 8109, Bethesda, MD 20892, 301-594-1182, 
robersos@mail.nih.gov.
    Name of Committee: National Cancer Institute Special Emphasis 
Panel, R25(E) Special Emphasis Panel (SEP).
    Date: February 12, 2008.
    Time: 5 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Crowne Plaza Washington Silver Spring, 8777 Georgia Ave., 
Silver Spring, MD 20910.
    Contact Person: Lynn M. Amende, PhD, Scientific Review 
Administrator, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Boulevard Room 8105 Bethesda, MD 20892-8328, 301-451-4759, 
amendel@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research, 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: December 4, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-6034 Filed 12-12-07; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.